CLASSICAL HODGKIN LYMPHOMA
Clinical trials for CLASSICAL HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSICAL HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSICAL HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against advanced Hodgkin's lymphoma
Disease control OngoingThis study tests a new combination of the drug camrelizumab plus chemotherapy (AVD) as the first treatment for people with advanced classical Hodgkin's lymphoma. The goal is to see if this combo can shrink or eliminate tumors better than standard care. About 60 adults aged 18 to …
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Apr 29, 2026 04:00 UTC
-
New drug combo targets Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new medicine, PF-08046032, alone and with another drug (sasanlimab) in adults with advanced lymphomas or solid tumors that have spread or not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the c…
Matched conditions: CLASSICAL HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 29, 2026 04:00 UTC